Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T43332 | Target Info | |||
Target Name | Coagulation factor VII (F7) | ||||
Synonyms | Serum prothrombin conversion accelerator; SPCA; Proconvertin; Eptacog alfa | ||||
Target Type | Successful Target | ||||
Gene Name | F7 | ||||
Biochemical Class | Peptidase | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | [(4S,5S)-4-[[(2S)-2-[[(2R)-2-acetamido-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-6-chloro-5-hydroxyhexyl]-(diaminomethylidene)azanium | Ligand Info | |||
Canonical SMILES | CC(=O)NC(CC1=CC=CC=C1)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(CCC[NH+]=C(N)N)C(CCl)O | ||||
InChI | 1S/C27H37ClN6O4/c1-18(35)32-22(15-19-9-4-2-5-10-19)25(37)34-23(16-20-11-6-3-7-12-20)26(38)33-21(24(36)17-28)13-8-14-31-27(29)30/h2-7,9-12,21-24,36H,8,13-17H2,1H3,(H,32,35)(H,33,38)(H,34,37)(H4,29,30,31)/p+1/t21-,22+,23-,24+/m0/s1 | ||||
InChIKey | SPENPXIFXGPVHG-UARRHKHWSA-O | ||||
PubChem Compound ID | 137347915 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 6R2W Crystal structure of the super-active FVIIa variant VYT in complex with tissue factor | ||||||
Method | X-ray diffraction | Resolution | 1.25 Å | Mutation | Yes | [1] |
PDB Sequence |
IVGGKVCPKG
25 ECPWQVLLLV35 NGAQLCGGTL45 INTIWVVSAA55 HCFDKIKNWR65 NLIAVLGEHD 75 LSEHDGDEQS85 RRVAQVIIPS95 TYVPGTTNHD105 IALLRLHQPV115 VLTDHVVPLC 125 LPERTFSERT135 LAFVRFSLVS145 GWGQLLDRGA155 TALELMVLNV165 PRVMTQDCEA 175 SYPGKITEYM185 FCAGYSDGSK195 DSCKGDSGGP205 HATHYRGTWY215 LTGIVSWGQG 225 CATVGHFGVY235 TRVSQYIEWL245 QKLMRSEPRP255 GVLLRAPFP
|
|||||
|
CYS41
3.649
ALA54
4.671
HIS56
1.433
CYS57
3.878
GLY100
2.509
THR101
2.592
THR102
2.018
ASP105
4.030
TYR177
4.721
LYS180
3.740
ASP196
1.944
SER197
2.052
CYS198
2.789
LYS199
2.253
GLY200
1.842
|
|||||
PDB ID: 4YLQ Crystal Structure of a FVIIa-Trypsin Chimera (FT) in Complex with Soluble Tissue Factor | ||||||
Method | X-ray diffraction | Resolution | 1.40 Å | Mutation | Yes | [2] |
PDB Sequence |
IVGGKVCPKG
25 ECPWQVLLLV35 NGAQLCGGTL46 INTIWVVSAA56 HCFDKIKNWR62 NLIAVLGEHD 72 LSEHDGDEQS82 RRVAQVIIPS92 TYVPGTTNHD102 IALLRLHQPV112 VLTDHVVPLC 122 LPERTFSERT129C LAFVRFSLVS139 GWGQLLDRGA150 TALELMVLNV160 PRLMTQDCEA 170 SFPGKITEYM180 FCAGYSDGSK188 DSCKGDSGGP198 HATHYRGTWY208 LTGIVSWGQG 218 CATVGHFGVY228 TRVSQYIEWL238 QKLMRSEPRP248 GVLLRAPFP
|
|||||
|
CYS41
3.576
ALA55
4.870
HIS57
1.452
CYS58
3.905
ASP60
3.521
TYR94
3.137
VAL95
4.768
PRO96
4.370
GLY97
2.389
THR98
2.291
THR99
2.402
ASN100
4.810
ASP102
2.838
ASP189
2.048
SER190
2.367
CYS191
2.649
LYS192
2.239
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Beating tissue factor at its own game: Design and properties of a soluble tissue factor-independent coagulation factor VIIa. J Biol Chem. 2020 Jan 10;295(2):517-528. | ||||
REF 2 | Molecular Basis of Enhanced Activity in Factor VIIa-Trypsin Variants Conveys Insights into Tissue Factor-mediated Allosteric Regulation of Factor VIIa Activity. J Biol Chem. 2016 Feb 26;291(9):4671-83. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.